FAST Start to BayBio’s team-based advisory program for startups
Four very promising Bay Area life science companies have begun meeting with high-level advisory teams tailored to their specific needs in BayBio’s new Fellows All-Star Team (FAST) Advisory program this fall. With generous support from Abbott Diabetes, BayBio developed FAST in order to help some of the most compelling young Bay Area life science companies fast-track their way to funding and success.
Glialogix, Inc., Omniox, Inc., Sandstone Diagnostics and Xcell Biosciences, Inc. comprise the 2013 cohort of FAST companies. Company founders have been paired with a team of 4-5 advisors who are meeting with them weekly for one-hour advising sessions through early December.
Rick Harkins (Bayer Healthcare), Ed Hurwitz (Alta Partners), David Lacey (formerly of Amgen), June Lee (UCSF), Greg Naeve (Pfizer) and Terry Rosen (formerly of Amgen) comprised the distinguished review panel that vetted and selected the four companies.
The program draws on a high-level team of serial entrepreneurs, researchers, investors and business advisors with expertise in clinical development, regulatory, reimbursement, relevant technical R&D, financing and business development. The teams provide FAST entrepreneurs with intensive team review and coaching to perfect their business model and develop a compelling commercialization strategy. These meetings will culminate in a final Pitch Showcase on December 12, which will include advisors, entrepreneurs and potential investors.